Inogen (INGN) Shareholder's Equity Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.37% |
| Dec 31, 2025 | -13.54% |
| Sep 30, 2025 | -17.48% |
| Jun 30, 2025 | -17.60% |
| Mar 31, 2025 | -17.94% |
| Dec 31, 2024 | -22.27% |
| Sep 30, 2024 | -22.02% |
| Jun 30, 2024 | -20.33% |
| Mar 31, 2024 | -18.64% |
| Dec 31, 2023 | -16.33% |
| Sep 30, 2023 | -13.19% |
| Jun 30, 2023 | -7.85% |
| Mar 31, 2023 | -6.78% |
| Dec 31, 2022 | -4.79% |
| Sep 30, 2022 | 0.74% |
| Jun 30, 2022 | 2.22% |
| Mar 31, 2022 | 3.63% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | 10.31% |
| Jun 30, 2021 | 11.59% |
| Mar 31, 2021 | 13.09% |
| Dec 31, 2020 | 15.48% |
| Sep 30, 2020 | 16.79% |
| Jun 30, 2020 | 19.11% |
| Mar 31, 2020 | 21.68% |
| Dec 31, 2019 | 23.70% |
| Sep 30, 2019 | 25.74% |
| Jun 30, 2019 | 27.19% |
| Mar 31, 2019 | 28.82% |
| Dec 31, 2018 | 32.31% |
| Sep 30, 2018 | 30.88% |
| Jun 30, 2018 | 27.78% |
| Mar 31, 2018 | 26.20% |
| Dec 31, 2017 | 24.32% |
| Sep 30, 2017 | 24.78% |
| Jun 30, 2017 | 23.31% |
| Mar 31, 2017 | 21.34% |
| Dec 31, 2016 | 70.07% |
| Mar 31, 2016 | 56.62% |
| Dec 31, 2015 | 54.10% |